First, the humoral immune responses to SARS-CoV-2 in COVID-19 patients were estimated by ELISA, and the levels of specific IgM and IgG antibodies were measured using N and recombinant S1 proteins and viral extracts as antigens. The gene discussed is PSMD1; the disease is COVID-19.